Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2501 Target Snapshot

B2 bradykinin receptor · SINGLE PROTEIN · Rattus norvegicus

97Compounds
12Assays
2Approved Drugs
82.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P25023. Use UniProt P25023 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P25023 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats B2 bradykinin receptor as ChEMBL target CHEMBL2501, mapped to UniProt P25023. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
B2 bradykinin receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2501
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P25023
B2 bradykinin receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether B2 bradykinin receptor is the right protein anchor across sources, using UniProt P25023 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelB2 bradykinin receptor
UniProt AccessionP25023
Component TypeProtein
Sequence Length396 aa

B2 bradykinin receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as B2 bradykinin receptor, mapped to UniProt P25023. Sequence length is 396 aa.

Mapped IDP25023
Review nameB2 bradykinin receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5025.0
KI42.0
KD15.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1907651 10.64 Ki 0.023 Preclinical
CHEMBL2028850 10.11 Ki 0.077 Approved
CHEMBL1907652 9.51 Ki 0.31 Preclinical
CHEMBL2028850 9.5 Kd 0.3162 Approved
CHEMBL406291 9.34 Ki 0.46 Clinical
CHEMBL3038099 9.31 Kd 0.4898 Preclinical
CHEMBL2112937 9.3 Ki 0.5 Preclinical
CHEMBL308468 9.3 Ki 0.5 Preclinical
CHEMBL2112044 9.22 Ki 0.6 Preclinical
CHEMBL431562 9.22 Ki 0.6 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
3
5.5
3
6.0
6
6.5
4
7.0
5
7.5
5
8.0
6
8.5
7
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

ICATIBANT
CHEMBL2028850
Approved 2008
Assay Landscape

Assay Landscape

12
Total Assays
27
Tested Compounds
2
Assay Types
Binding — 8 assays, 27 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 3 23 7.6
cell-based format 2 3 9.2
tissue-based format 2 0
assay format 1 1 6.4
Functional — 4 assays, 19 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 3 17 8.0
cell-based format 1 2 6.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine